SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing a wave of retail speculation as traders debate its potential for a recovery amidst persistent market volatility and heavy selling pressure. The community remains deeply divided, with many users actively accumulating shares on dips while others express skepticism, citing concerns about its inflationary supply and reliance on social sentiment.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is rallying following the release of its Muse Spark 1.1 AI model and reports that the company plans to begin manufacturing in-house AI chips in September to significantly expand its computing capacity. Community sentiment has shifted sharply toward bullish, with many investors viewing the vertical integration of chips, models, and massive user data as a competitive advantage that outweighs recent concerns regarding heavy capital expenditure.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase is experiencing significant market volatility driven by discussions surrounding the potential passage of the Clarity Act and ongoing leadership changes. Investors are closely monitoring regulatory developments, with sentiment deeply divided between anticipation of a major breakout and concerns over the stock's failure to maintain momentum alongside Bitcoin.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is experiencing significant volatility driven by intense debate over its transition into an enterprise-wide agentic AI orchestration layer. Investors are actively discussing the stock's massive short interest and heavy volume as potential catalysts for a squeeze, while balancing these technical factors against the company's GAAP profitability, cash-rich balance sheet, and persistent price stagnation.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is seeing a surge in trading volume and bullish sentiment as market participants anticipate the upcoming housing legislation and monitor the company's progress toward improved margins and profitability. Community discussions are heavily focused on the potential for a short squeeze and a technical breakout, with traders debating whether the current accumulation phase signals a sustainable turnaround for the real estate technology platform.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending following a significant leadership shakeup that saw the departure of CEO David Gandler and the appointment of former Disney executive Alisa Bowen, sparking intense community debate over whether this represents a long-awaited turnaround or another failed attempt to salvage a struggling business model. While some traders are optimistic that Disneys involvement signals a strategic pivot, others remain deeply skeptical, citing ongoing concerns about dilution, poor historical performance, and the company's competitive position in the streaming space.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging as a follow-on production order from a major silicon photonics customer reinforces the company's critical role in testing hardware for high-growth AI data center and optical interconnect applications. Investors are actively discussing the stock's role as a picks-and-shovels play in the AI hardware supply chain, with community sentiment split between conviction in its long-term capacity expansion and concerns over high valuation premiums following its recent rally.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending following the strategic acquisition of DZYNE Technologies and associated revenue guidance updates, which have drawn significant community debate over the company's aggressive growth-by-acquisition strategy versus share dilution concerns. Investors are actively discussing the firm's role in the defense and counter-drone sector, citing potential integration with major partners like Palantir and the impact of increasing geopolitical demand on future performance.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

The SPDR Gold Shares ETF (GLD) is trending as gold prices face downward pressure despite lingering geopolitical tensions and high sovereign debt, with the community actively debating whether current support levels signal a long-term buying opportunity or a deeper correction. Market participants are split between those viewing the pullback as a structural dip caused by hawkish rate expectations and a strong dollar, and others who remain bullish, citing central bank gold accumulation as a critical floor for the asset.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant investor attention following reports of a strategic collaboration with Aramco Digital to advance sovereign secure communications and industrial technology in Saudi Arabia. The community is actively debating the long-term implications of this potential partnership, with many viewing it as a major catalyst for the company's QNX platform and cybersecurity expansion while dismissing recent insider selling as standard programmatic activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cytokinetics Gains 18.4% Year to Date: How to Play the Stock?

CYTK has gained 18.4% YTD as Myqorzo's FDA approval, early launch momentum, and expanding market opportunities fuel investor interest.

Can BMY's Camzyos Strengthen Its Cardiovascular Portfolio?

Bristol Myers eyes growth from Camzyos as the FDA reviews its use in adolescents with obstructive HCM, expanding the drug's market reach.

Top Analyst Reports for Costco, Lam Research & KLA

Costco, Lam Research and KLA headline Zacks' top analyst reports, with AI demand, digital investments and expansion plans driving focus.

Why Is Cytokinetics (CYTK) Down 5.5% Since Last Earnings Report?

Cytokinetics (CYTK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CYTK Q1 Earnings Match Estimates, Revenues Beat on Myqorzo Launch

Cytokinetics posts Q1 loss as Myqorzo launch lifts revenues to $19.4M, signaling commercial shift amid rising SG&A tied to rollout and expansion.

Cytokinetics (NASDAQ:CYTK) Posts Quarterly Earnings Results

Cytokinetics (NASDAQ:CYTK - Get Free Report) issued its quarterly earnings results on Tuesday. The biopharmaceutical company reported ($1.67) EPS for the quarter, hitting analysts' consensus estimates of ($1.67). The business had revenue of $19.36 million for the quarter, compared to analyst...

Cytokinetics Q1 Earnings Call Highlights

Cytokinetics (NASDAQ:CYTK) highlighted the first full quarter as a commercial-stage company during its first-quarter 2026 earnings call, pointing to early U.S. demand for its newly launched...

Cytokinetics (NASDAQ:CYTK) EVP Sells $270,795.00 in Stock

Cytokinetics, Incorporated (NASDAQ:CYTK - Get Free Report) EVP Fady Ibraham Malik sold 3,500 shares of Cytokinetics stock in a transaction on Tuesday, May 5th. The stock was sold at an average price of $77.37, for a total value of $270,795.00. Following the sale, the executive vice president...

Cytokinetics Shares Phase 3 ACACIA-HCM Win: Aficamten Hits Dual Endpoints in nHCM Trial

Cytokinetics (NASDAQ:CYTK) reported positive top-line results from ACACIA-HCM, a pivotal Phase 3 trial evaluating aficamten in patients with symptomatic non-obstructive hypertrophic cardiomyopathy...

Cytokinetics (CYTK) Reports Q1 Loss, Beats Revenue Estimates

Cytokinetics (CYTK) delivered earnings and revenue surprises of -0.20% and +173.34%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics?

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

CYTKCytokinetics Inc

Fundamentals

Latest CYTK News